| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Detected but not Quantified |
|---|
| Creation Date | 2021-09-11 13:25:53 UTC |
|---|
| Update Date | 2021-09-26 23:08:05 UTC |
|---|
| HMDB ID | HMDB0254237 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide |
|---|
| Description | N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide belongs to the class of organic compounds known as carbazoles. Carbazoles are compounds containing a three ring system containing a pyrrole ring fused on either side to a benzene ring. Based on a literature review very few articles have been published on N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide. This compound has been identified in human blood as reported by (PMID: 31557052 ). N-[(6r)-6-(dimethylamino)-6,7,8,9-tetrahydro-5h-carbazol-3-yl]-4-fluorobenzamide is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
|---|
| Structure | CN(C)C1CCC2=C(C1)C1=C(N2)C=CC(NC(=O)C2=CC=C(F)C=C2)=C1 InChI=1S/C21H22FN3O/c1-25(2)16-8-10-20-18(12-16)17-11-15(7-9-19(17)24-20)23-21(26)13-3-5-14(22)6-4-13/h3-7,9,11,16,24H,8,10,12H2,1-2H3,(H,23,26) |
|---|
| Synonyms | Not Available |
|---|
| Chemical Formula | C21H22FN3O |
|---|
| Average Molecular Weight | 351.425 |
|---|
| Monoisotopic Molecular Weight | 351.174690503 |
|---|
| IUPAC Name | N-[3-(dimethylamino)-2,3,4,9-tetrahydro-1H-carbazol-6-yl]-4-fluorobenzamide |
|---|
| Traditional Name | N-[6-(dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | CN(C)C1CCC2=C(C1)C1=C(N2)C=CC(NC(=O)C2=CC=C(F)C=C2)=C1 |
|---|
| InChI Identifier | InChI=1S/C21H22FN3O/c1-25(2)16-8-10-20-18(12-16)17-11-15(7-9-19(17)24-20)23-21(26)13-3-5-14(22)6-4-13/h3-7,9,11,16,24H,8,10,12H2,1-2H3,(H,23,26) |
|---|
| InChI Key | GKWHICIUSVVNGX-UHFFFAOYSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as carbazoles. Carbazoles are compounds containing a three ring system containing a pyrrole ring fused on either side to a benzene ring. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Organoheterocyclic compounds |
|---|
| Class | Indoles and derivatives |
|---|
| Sub Class | Carbazoles |
|---|
| Direct Parent | Carbazoles |
|---|
| Alternative Parents | |
|---|
| Substituents | - Carbazole
- 4-halobenzoic acid or derivatives
- Halobenzoic acid or derivatives
- 3-alkylindole
- Benzamide
- Benzoic acid or derivatives
- Indole
- Benzoyl
- Aralkylamine
- Fluorobenzene
- Halobenzene
- Benzenoid
- Aryl fluoride
- Aryl halide
- Monocyclic benzene moiety
- Pyrrole
- Heteroaromatic compound
- Tertiary aliphatic amine
- Tertiary amine
- Secondary carboxylic acid amide
- Amino acid or derivatives
- Carboxamide group
- Azacycle
- Carboxylic acid derivative
- Organooxygen compound
- Organic oxide
- Amine
- Organic oxygen compound
- Hydrocarbon derivative
- Organic nitrogen compound
- Organohalogen compound
- Organofluoride
- Organonitrogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Not Available |
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross Sections| Predictor | Adduct Type | CCS Value (Å2) | Reference |
|---|
| DeepCCS | [M+H]+ | 193.397 | 30932474 | | DeepCCS | [M-H]- | 191.039 | 30932474 | | DeepCCS | [M-2H]- | 225.086 | 30932474 | | DeepCCS | [M+Na]+ | 200.314 | 30932474 |
Predicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Predicted by Siyang on May 30, 2022 | 11.1034 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 3.08 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 1519.4 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 213.2 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 131.4 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 166.3 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 133.2 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 330.0 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 403.0 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 577.8 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 867.3 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 345.5 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 1233.7 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 293.3 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 285.0 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 350.4 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 366.4 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 25.1 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide,1TMS,isomer #1 | CN(C)C1CCC2=C(C1)C1=CC(NC(=O)C3=CC=C(F)C=C3)=CC=C1N2[Si](C)(C)C | 3272.7 | Semi standard non polar | 33892256 | | N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide,1TMS,isomer #1 | CN(C)C1CCC2=C(C1)C1=CC(NC(=O)C3=CC=C(F)C=C3)=CC=C1N2[Si](C)(C)C | 3008.4 | Standard non polar | 33892256 | | N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide,1TMS,isomer #1 | CN(C)C1CCC2=C(C1)C1=CC(NC(=O)C3=CC=C(F)C=C3)=CC=C1N2[Si](C)(C)C | 3638.0 | Standard polar | 33892256 | | N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide,1TMS,isomer #2 | CN(C)C1CCC2=C(C1)C1=CC(N(C(=O)C3=CC=C(F)C=C3)[Si](C)(C)C)=CC=C1[NH]2 | 3050.6 | Semi standard non polar | 33892256 | | N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide,1TMS,isomer #2 | CN(C)C1CCC2=C(C1)C1=CC(N(C(=O)C3=CC=C(F)C=C3)[Si](C)(C)C)=CC=C1[NH]2 | 3025.4 | Standard non polar | 33892256 | | N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide,1TMS,isomer #2 | CN(C)C1CCC2=C(C1)C1=CC(N(C(=O)C3=CC=C(F)C=C3)[Si](C)(C)C)=CC=C1[NH]2 | 3683.8 | Standard polar | 33892256 | | N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide,2TMS,isomer #1 | CN(C)C1CCC2=C(C1)C1=CC(N(C(=O)C3=CC=C(F)C=C3)[Si](C)(C)C)=CC=C1N2[Si](C)(C)C | 3038.2 | Semi standard non polar | 33892256 | | N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide,2TMS,isomer #1 | CN(C)C1CCC2=C(C1)C1=CC(N(C(=O)C3=CC=C(F)C=C3)[Si](C)(C)C)=CC=C1N2[Si](C)(C)C | 2979.2 | Standard non polar | 33892256 | | N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide,2TMS,isomer #1 | CN(C)C1CCC2=C(C1)C1=CC(N(C(=O)C3=CC=C(F)C=C3)[Si](C)(C)C)=CC=C1N2[Si](C)(C)C | 3400.7 | Standard polar | 33892256 | | N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide,1TBDMS,isomer #1 | CN(C)C1CCC2=C(C1)C1=CC(NC(=O)C3=CC=C(F)C=C3)=CC=C1N2[Si](C)(C)C(C)(C)C | 3478.0 | Semi standard non polar | 33892256 | | N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide,1TBDMS,isomer #1 | CN(C)C1CCC2=C(C1)C1=CC(NC(=O)C3=CC=C(F)C=C3)=CC=C1N2[Si](C)(C)C(C)(C)C | 3223.1 | Standard non polar | 33892256 | | N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide,1TBDMS,isomer #1 | CN(C)C1CCC2=C(C1)C1=CC(NC(=O)C3=CC=C(F)C=C3)=CC=C1N2[Si](C)(C)C(C)(C)C | 3718.8 | Standard polar | 33892256 | | N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide,1TBDMS,isomer #2 | CN(C)C1CCC2=C(C1)C1=CC(N(C(=O)C3=CC=C(F)C=C3)[Si](C)(C)C(C)(C)C)=CC=C1[NH]2 | 3309.4 | Semi standard non polar | 33892256 | | N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide,1TBDMS,isomer #2 | CN(C)C1CCC2=C(C1)C1=CC(N(C(=O)C3=CC=C(F)C=C3)[Si](C)(C)C(C)(C)C)=CC=C1[NH]2 | 3232.8 | Standard non polar | 33892256 | | N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide,1TBDMS,isomer #2 | CN(C)C1CCC2=C(C1)C1=CC(N(C(=O)C3=CC=C(F)C=C3)[Si](C)(C)C(C)(C)C)=CC=C1[NH]2 | 3767.9 | Standard polar | 33892256 | | N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide,2TBDMS,isomer #1 | CN(C)C1CCC2=C(C1)C1=CC(N(C(=O)C3=CC=C(F)C=C3)[Si](C)(C)C(C)(C)C)=CC=C1N2[Si](C)(C)C(C)(C)C | 3447.1 | Semi standard non polar | 33892256 | | N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide,2TBDMS,isomer #1 | CN(C)C1CCC2=C(C1)C1=CC(N(C(=O)C3=CC=C(F)C=C3)[Si](C)(C)C(C)(C)C)=CC=C1N2[Si](C)(C)C(C)(C)C | 3369.7 | Standard non polar | 33892256 | | N-[(6R)-6-(Dimethylamino)-6,7,8,9-tetrahydro-5H-carbazol-3-yl]-4-fluorobenzamide,2TBDMS,isomer #1 | CN(C)C1CCC2=C(C1)C1=CC(N(C(=O)C3=CC=C(F)C=C3)[Si](C)(C)C(C)(C)C)=CC=C1N2[Si](C)(C)C(C)(C)C | 3565.7 | Standard polar | 33892256 |
|
|---|